Issue 1/2014

The role of tumor markers and biomarkers in colorectal cancer (1 — 8)

G. LECH, R. SLOTWINSKI, I. W. KRASNODEBSKI

DOI: 10.4149/neo_2014_003

Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2β expression to TMPRSS2-ERG fusion status in prostate cancer (9 — 16)

Z. KOLAR, A. BURDOVA, T. JAMASPISHVILI, J. BOUCHAL, R. KUCEROVA, M. BIENOVA, M. KRAL, V. STUDENT

DOI: 10.4149/neo_2014_004

Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ –MALDI-MS/MS (17 — 26)

X. HE, Y. WANG, W. ZHANG, H. LI, R. LUO, Y. ZHOU, C. LI,M. LIAO, H. HUANG, X. LV, Z. XIE, M. HE

DOI: 10.4149/neo_2014_001

MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3 (27 — 34)

S. QIN, Y. ZHU, F. AI, Y. LI, B. BAI, W. YAO, L. DONG

DOI: 10.4149/neo_2014_005

Prognostic implication of TIM-3 in clear cell renal cell carcinoma (35 — 40)

J. YUAN, B. JIANG, H. ZHAO, Q. HUANG

DOI: 10.4149/neo_2014_006

Cyclin-dependent kinase 1 inhibitor RO3306 promotes mitotic slippage in paclitaxel-treated HepG2 cells (41 — 47)

J. XIAO, P. QIU, X. LAI, P. HE, Y. WU, B. DU, Y. TAN

DOI: 10.4149/neo_2014_007

Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH (48 — 55)

J. SMETANA, E. DEMENTYEVA, F. KRYUKOV, P. NEMEC, H. GRESLIKOVA, R. KUPSKA, A. MIKULASOVA, I. IHNATOVA, R. HAJEK, P. KUGLIK

DOI: 10.4149/neo_2014_008

INCB018424 induces apoptotic cell death through the suppression of pJAK1 in human colon cancer cells (56 — 62)

H. J. AN, E. K. CHOI, J. S. KIM, S. W. HONG, J. H. MOON, J. S. SHIN, S. H. HA, K. P. KIM, Y. S. HONG, J. L. LEE, E. K. CHOI, J. S. LEE, D. H. JIN, T. W. KIM

DOI: 10.4149/neo_2014_009

A polymorphism in the 3’ untranslated region of Hypoxia-Inducible Factor-1 alpha confers an increased risk of cervical cancer in a Chinese population (63 — 69)

S. L. FU, J. MIAO, B. DING, X. L. WANG, W. J. CHENG, H. H. DAI, S. P. HAN

DOI: 10.4149/neo_2014_002

ATM and TGFB1 genes polymorphisms in prediction of late complications of chemoradiotherapy in patients with locally advanced cervical cancer (70 — 76)

S. PAULIKOVA, J. PETERA, I. SIRAK, M. VOSMIK, M. DRASTIKOVA, L. DUSEK, M. CVANOVA, R. SOUMAROVA, J. SPACEK, M. BERANEK

DOI: 10.4149/neo_2014_010

Creatinine clearance rate and serum creatinine concentration are related to delayed methotrexate elimination in children with lymphoblastic malignancies (77 — 82)

J. MAO, L. ZHANG, H. SHEN, Y. TANG, H. SONG, F. ZHAO, W. XU

DOI: 10.4149/neo_2014_011

Decreased expression of Small glutamine-rich tetratricopeptide repeat-containing protein (SGT) correlated with prognosis of Hepatocellular carcinoma (83 — 89)

J. ZHANG, C. LU, S. HE, C. WAN, Y. ZHANG, C. CHENG

DOI: 10.4149/neo_2014_012

Cellular and humoral immunodeficiency in breast cancer patients resistant to hormone therapy (90 — 98)

E. ZAVADOVA, M. VOCKA, J. SPACEK, B. KONOPASEK, T. FUCIKOVA, L. PETRUZELKA

DOI: 10.4149/neo_2014_013

Relationship between the Expression of CES2, UGT1A1, and GUSB in colorectal cancer tissues and aberrant methylation (99 — 109)

F. W. XIE, Y. H. PENG, XIONG CHEN, XI CHEN, J. LI, W. W. WANG, Z. Y. YU, X. N. OUYANG

DOI: 10.4149/neo_2014_014

Ethnic disparities in breast cancer between Central Europe Caucasian women of Slavic origin and Middle East Turkish subjects (110 — 117)

P. ZUBOR, M. CALISKAN,K. KAJO, G. SOYBIR, C. TOPUZLU, J. DANKO

DOI: 10.4149/neo_2014_015